A global biopharmaceutical company focused on developing life-changing therapies for people living with rare disorders.

Deployed a literature specialist team and adopted the following approach
Recurring surveillance and reporting helped the client team stay abreast of changes/updates in the targeted therapy area for client and competitor molecules under development. Further, this hub model setup reduced the time and cost of delivering literature reviews. Quality improvements and enhanced audit readiness were achieved with enhanced visibility into the literature portfolio and team productivity.
~40%
Cost reduction
100%
Regulatory and timeline compliance
100%
Accurate identification and management of literature